tiprankstipranks
Editas Medicine Inc (EDIT)
NASDAQ:EDIT

Editas Medicine (EDIT) Technical Analysis

3,124 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Editas Medicine Inc’s (EDIT) Moving Averages Convergence Divergence (MACD) indicator is -0.11, suggesting Editas Medicine Inc is a Sell.
Editas Medicine Inc’s (EDIT) 20-Day exponential moving average is 5.72, while Editas Medicine Inc’s (EDIT) share price is $5.63, making it a Sell.
Editas Medicine Inc’s (EDIT) 50-Day exponential moving average is 6.27, while Editas Medicine Inc’s (EDIT) share price is $5.63, making it a Sell.

Editas Medicine (EDIT) Pivot Points

May 26, 2024, 11:26 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.24
5.45
5.64
5.85
6.04
6.24
6.43
Fibonacci
5.45
5.60
5.69
5.85
6.00
6.09
6.24
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Editas Medicine (EDIT) Moving Averages

May 26, 2024, 11:26 AM
Period
Simple
Exponential
MA5
5.70Sell
5.73Sell
MA10
5.74Sell
5.70Sell
MA20
5.60Buy
5.72Sell
MA50
6.23Sell
6.27Sell
MA100
7.32Sell
7.03Sell
MA200
8.00Sell
7.67Sell
Editas Medicine Inc’s (EDIT) 10-Day exponential moving average is 5.70, while Editas Medicine Inc’s (EDIT) share price is $5.63, making it a Sell.
Editas Medicine Inc’s (EDIT) 100-Day exponential moving average is 7.03, while Editas Medicine Inc’s (EDIT) share price is $5.63, making it a Sell.
Editas Medicine Inc’s (EDIT) stock price is $5.63 and Editas Medicine Inc’s (EDIT) 50-day simple moving average is 6.23, creating a Sell signal.
Editas Medicine Inc’s (EDIT) stock price is $5.63 and Editas Medicine Inc’s (EDIT) 100-day simple moving average is 7.32, creating a Sell signal.
Editas Medicine Inc’s (EDIT) stock price is $5.63 and Editas Medicine Inc’s (EDIT) 200-day simple moving average is 8.00, creating a Sell signal.

Editas Medicine (EDIT) Technical Indicators

May 26, 2024, 11:26 AM
Name
Value
Implied Action
RSI (14)
46.51
Neutral
STOCH (9,6)
35.64
Neutral
STOCHRSI (14)
51.50
Neutral
MACD (12,26)
-0.11
Sell
ADX (14)
17.95
Buy
Williams %R
-59.55
Buy
CCI (14)
29.37
Neutral
ATR (14)
0.43
-
Ultimate Oscillator
37.87
Neutral
ROC
-0.53
Sell
Editas Medicine Inc’s (EDIT) Relative Strength Index (RSI) is 46.51, creating a Neutral signal.
Editas Medicine Inc’s (EDIT) Trend Strength Indicator (ADX) is 17.95, creating a Buy signal.
Editas Medicine Inc’s (EDIT) Commodity Channel Index (CCI) is 29.37, creating a Neutral signal.
Editas Medicine Inc’s (EDIT) Price Rate of Change (ROC) is -0.53, creating a Sell signal.

FAQ

Is EDIT a Buy, Hold, or Sell?
Based on EDIT’s technical indicators, EDIT is a Sell.
    What is EDIT’s RSI (14)?
    EDIT’s RSI (14) is 46.51, which suggests EDIT is a Neutral.
      What is EDIT’s MACD?
      EDIT’s MACD is -0.11, which suggests EDIT is a Sell.
        What is EDIT’s 5-day moving average?
        EDIT’s 5-day moving average is 5.70, which suggests EDIT is a Sell.
          What is EDIT’s 20-day moving average?
          EDIT 20-day moving average is 5.60, which suggests EDIT is a Buy.
            What is EDIT’s 50-day moving average?
            EDIT’s 50-day moving average is 6.23, which suggests EDIT is a Sell.
              What is EDIT’s 200-day moving average?
              EDIT’s 200-day moving average is 8.00, which suggests EDIT is a Sell.
                What is EDIT’s Williams % R (14)?
                EDIT’s Williams % R (14) is -59.55, which suggests EDIT is a Buy.
                  What is EDIT’s CCI (14)?
                  EDIT’s CCI (14) is 29.37, which suggests EDIT is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis